Accession Number: | 0001127602-19-034365 |
Date: | 2019-12-04 |
Issuer: | CONMED CORP (CNMD) |
Original Submission Date: |
KENNEDY JOHN JED
C/O CONMED CORPORATION
525 FRENCH ROAD
UTICA, NY 13502
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-04 | M | 14,820 | a | $39.87 | 19,317 | direct | ||
COMMON STOCK | 2019-12-04 | F | 8,432 | d | $114.81 | 10,885 | direct | ||
COMMON STOCK | 2019-12-04 | M | 10,000 | a | $41.93 | 20,885 | direct | ||
COMMON STOCK | 2019-12-04 | F | 6,469 | d | $114.92 | 14,416 | direct | ||
COMMON STOCK | 2019-12-04 | M | 5,400 | a | $59.96 | 19,816 | direct | ||
COMMON STOCK | 2019-12-04 | F | 3,965 | d | $114.92 | 15,851 | direct | ||
COMMON STOCK | 2019-12-04 | S | 11,354 | d | $115.03 | 4,497 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTIONS TO PURCHASE COMMON STOCK | 39.87 | 2019-12-04 | deemed execution date | M | 14,820 (d) | 2026-03-01 | common stock 14,820 | $39.87 | 9,880 | direct | ||
OPTIONS TO PURCHASE COMMON STOCK | 41.93 | 2019-12-04 | deemed execution date | M | 10,000 (d) | 2027-03-01 | common stock 10,000 | $41.93 | 15,000 | direct | ||
OPTIONS TO PURCHASE COMMON STOCK | 59.96 | 2019-12-04 | deemed execution date | M | 5,400 (d) | 2028-03-01 | common stock 5,400 | $59.96 | 21,600 | direct |
ID | footnote |
---|---|
f1 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $114.66 to $115.41. full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, conmed, or a conmed security holder. |
f2 | the stock options were granted under the company's 2015 amended and restated long-term incentive plan and generally vest in equal amounts over a five year period |